Literature DB >> 31911736

The Brave New World of Gene Editing and Molecular Medicine.

Joel C Eissenberg1.   

Abstract

Gene therapy has long been a promise of molecular biology. So far, that promise has largely been unrealized. The advent of gene editing using technology adapted from bacteria may finally usher in the era of gene therapy. Copyright 2019 by the Missouri State Medical Association.

Mesh:

Year:  2019        PMID: 31911736      PMCID: PMC6913842     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  16 in total

1.  Academies' action plan for germline editing.

Authors:  Victor J Dzau; Marcia McNutt; Venki Ramakrishnan
Journal:  Nature       Date:  2019-03       Impact factor: 49.962

Review 2.  CRISPR-Cas9 Structures and Mechanisms.

Authors:  Fuguo Jiang; Jennifer A Doudna
Journal:  Annu Rev Biophys       Date:  2017-03-30       Impact factor: 12.981

Review 3.  The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia.

Authors:  Javier Costas
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-30       Impact factor: 3.568

Review 4.  Chemokine control of West Nile virus infection.

Authors:  Jean K Lim; Philip M Murphy
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

5.  Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi.

Authors:  Valentino M Gantz; Nijole Jasinskiene; Olga Tatarenkova; Aniko Fazekas; Vanessa M Macias; Ethan Bier; Anthony A James
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

Review 6.  A new era of gene editing for the treatment of human diseases.

Authors:  Mandip Kc; Clifford John Steer
Journal:  Swiss Med Wkly       Date:  2019-01-27       Impact factor: 2.193

7.  Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA.

Authors:  R Jaenisch; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

Review 8.  CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).

Authors:  Ewa Kruminis-Kaszkiel; Judyta Juranek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

9.  CRISPR/Cas9 -mediated gene knockout of Anopheles gambiae FREP1 suppresses malaria parasite infection.

Authors:  Yuemei Dong; Maria L Simões; Eric Marois; George Dimopoulos
Journal:  PLoS Pathog       Date:  2018-03-08       Impact factor: 6.823

Review 10.  Concerning RNA-guided gene drives for the alteration of wild populations.

Authors:  Kevin M Esvelt; Andrea L Smidler; Flaminia Catteruccia; George M Church
Journal:  Elife       Date:  2014-07-17       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.